| 46.05 -0.67 (-1.43%) | 10-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 54.44  |
1-year : | 56.35 |
| Resists | First : | 46.61 |
Second : | 48.25 |
| Pivot price | 45.76 |
|||
| Supports | First : | 43.97 |
Second : | 36.58 |
| MAs | MA(5) : | 46.07  |
MA(20) : | 45.77 |
| MA(100) : | 43.18 |
MA(250) : | 41.53 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 62.3 |
D(3) : | 53.4 |
| RSI | RSI(14): 49.6 |
|||
| 52-week | High : | 53.65 | Low : | 31.44 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CNMD ] has closed below upper band by 42.6%. Bollinger Bands are 41.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 47.12 - 47.41 | 47.41 - 47.62 |
| Low: | 45.19 - 45.56 | 45.56 - 45.82 |
| Close: | 45.57 - 46.11 | 46.11 - 46.48 |
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
Sun, 18 Oct 2026
CNMD Stock Hits Highest Level In Over Four Months – Why JPMorgan Believes Firm Would Be Highly Attractive To ‘Financial Acquirers’ - Stocktwits
Sat, 17 Oct 2026
CONMED Corporation (CNMD) Stock Forecasts - Yahoo! Finance Canada
Sat, 17 Oct 2026
Slowing Sales Growth Might Change The Case For Investing In CONMED Stock (CNMD) - Simply Wall Street
Fri, 16 Oct 2026
Top CONMED (CNMD) Competitors 2026 - MarketBeat
Fri, 16 Oct 2026
CONMED (CNMD) Stock Price, News & Analysis - MarketBeat
Thu, 15 Oct 2026
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 116.6 (%) |
| Shares Short | 1,960 (K) |
| Shares Short P.Month | 2,260 (K) |
| EPS | 1.85 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 34.72 |
| Profit Margin | 4.1 % |
| Operating Margin | 14.6 % |
| Return on Assets (ttm) | 4.1 % |
| Return on Equity (ttm) | 5.5 % |
| Qtrly Rev. Growth | 0.3 % |
| Gross Profit (p.s.) | 25.45 |
| Sales Per Share | 45.74 |
| EBITDA (p.s.) | 7.59 |
| Qtrly Earnings Growth | 11.1 % |
| Operating Cash Flow | 151 (M) |
| Levered Free Cash Flow | 131 (M) |
| PE Ratio | 24.89 |
| PEG Ratio | 1.8 |
| Price to Book value | 1.32 |
| Price to Sales | 1 |
| Price to Cash Flow | 9.15 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|